{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:30:33Z","timestamp":1761708633462},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,2,16]],"date-time":"2011-02-16T00:00:00Z","timestamp":1297814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00428-011-1051-8","type":"journal-article","created":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T18:18:15Z","timestamp":1297793895000},"page":"477-486","source":"Crossref","is-referenced-by-count":17,"title":["Kidney histologic alterations in \u03b1-Galactosidase-deficient mice"],"prefix":"10.1007","volume":"458","author":[{"given":"Carmen","family":"Valbuena","sequence":"first","affiliation":[]},{"given":"Jo\u00e3o Paulo","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"F\u00e1tima","family":"Carneiro","sequence":"additional","affiliation":[]},{"given":"Sandra","family":"Relvas","sequence":"additional","affiliation":[]},{"given":"Mariana","family":"Ganh\u00e3o","sequence":"additional","affiliation":[]},{"given":"M. Clara","family":"S\u00e1-Miranda","sequence":"additional","affiliation":[]},{"given":"Lorena G.","family":"Rodrigues","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,2,16]]},"reference":[{"key":"1051_CR1","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1073\/pnas.85.11.3903","volume":"85","author":"DF Bishop","year":"1988","unstructured":"Bishop DF, Kornreich R, Desnick RJ (1988) Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3' untranslated region. Proc Natl Acad Sci USA 85:3903\u20133907","journal-title":"Proc Natl Acad Sci USA"},{"key":"1051_CR2","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","volume":"276","author":"RO Brady","year":"1967","unstructured":"Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L (1967) Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. N Engl J Med 276:1163\u20131167","journal-title":"N Engl J Med"},{"key":"1051_CR3","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.167.3922.1268","volume":"167","author":"JA Kint","year":"1970","unstructured":"Kint JA (1970) Fabry's disease: alpha-galactosidase deficiency. Science 167:1268\u20131269","journal-title":"Science"},{"key":"1051_CR4","first-page":"3733","volume-title":"The metabolic bases of inherited disease","author":"RJ Desnick","year":"2001","unstructured":"Desnick RJ, Ioannou YA, Eng CM (2001) Alpha-Galactosidase A deficiency: Fabry disease. In: Scriver C, Beaudet A, Sly W, Valle D (eds) The metabolic bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 3733\u20133774","edition":"8"},{"key":"1051_CR5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","volume":"138","author":"RJ Desnick","year":"2003","unstructured":"Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, Grabowski G, Packman S, Wilcox WR (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338\u2013346","journal-title":"Ann Intern Med"},{"key":"1051_CR6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","volume":"81","author":"MH Branton","year":"2002","unstructured":"Branton MH, Schiffmann R, Sabnis SG, Murray GJ, Quirk JM, Altarescu G, Goldfarb L, Brady RO, Balow JE, Austin Iii HA, Kopp JB (2002) Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine 81:122\u2013138","journal-title":"Medicine"},{"key":"1051_CR7","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","volume":"24","author":"R Schiffmann","year":"2009","unstructured":"Schiffmann R, Warnock DG, Banikazemi M, Bultas J, Linthorst GE, Packman S, Sorensen SA, Wilcox WR, Desnick RJ (2009) Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy. Nephrol Dial Transplant 24:2102\u20132111","journal-title":"Nephrol Dial Transplant"},{"key":"1051_CR8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ki.1978.32","volume":"13","author":"MC Gubler","year":"1978","unstructured":"Gubler MC, Lenoir G, Grunfeld JP, Ulmann A, Droz D, Habib R (1978) Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int 13:223\u2013235","journal-title":"Kidney Int"},{"key":"1051_CR9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1023\/A:1012423924648","volume":"24","author":"A Sessa","year":"2001","unstructured":"Sessa A, Meroni M, Battini G, Maglio A, Brambilla PL, Bertella M, Nebuloni M, Pallotti F, Giordano F, Bertagnolio B, Tosoni A (2001) Renal pathological changes in Fabry disease. J Inherit Metab Dis 24:66\u201370","journal-title":"J Inherit Metab Dis"},{"key":"1051_CR10","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1097\/01.ASN.0000016684.07368.75","volume":"13","author":"J Alroy","year":"2002","unstructured":"Alroy J, Sabnis S, Kopp JB (2002) Renal pathology in Fabry disease. J Am Soc Nephrol 13:S134\u2013S138","journal-title":"J Am Soc Nephrol"},{"key":"1051_CR11","first-page":"109","volume":"15","author":"A Sessa","year":"2002","unstructured":"Sessa A, Toson A, Nebuloni M, Pallotti F, Giordano F, Battini G, Maglio A, Meroni M, Calconi G, Bertolone G, Gatti P (2002) Renal ultrastructural findings in Anderson-Fabry disease. J Nephrol 15:109\u2013112","journal-title":"J Nephrol"},{"key":"1051_CR12","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/modpathol.3800634","volume":"19","author":"EG Fischer","year":"2006","unstructured":"Fischer EG, Moore MJ, Lager DJ (2006) Fabry disease: a morphologic study of 11 cases. Mod Pathol 19:1295\u20131301","journal-title":"Mod Pathol"},{"key":"1051_CR13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1053\/j.ajkd.2007.12.032","volume":"51","author":"C T\u00f8ndel","year":"2008","unstructured":"T\u00f8ndel C, Bostad L, Hirth A, Svarstad E (2008) Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria. Am J Kidney Dis 51:767\u2013776","journal-title":"Am J Kidney Dis"},{"key":"1051_CR14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00428-008-0653-2","volume":"453","author":"C Valbuena","year":"2008","unstructured":"Valbuena C, Carvalho E, Bustorff M, Ganhao M, Relvas S, Nogueira R, Carneiro F, Oliveira JP (2008) Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy. Virchows Arch 453:329\u2013338","journal-title":"Virchows Arch"},{"key":"1051_CR15","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1093\/ndt\/gfp528","volume":"25","author":"AB Fogo","year":"2010","unstructured":"Fogo AB, Bostad L, Svarstad E, Cook WJ, Moll S, Barbey F, Geldenhuys L, West M, Ferluga D, Vujkovac B, Howie AJ, Burns A, Reeve R, Waldek S, Noel LH, Grunfeld JP, Valbuena C, Oliveira JP, Muller J, Breunig F, Zhang X, Warnock DG (2010) Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN). Nephrol Dial Transplant 25:2168\u20132177","journal-title":"Nephrol Dial Transplant"},{"key":"1051_CR16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ (2001) Safety and efficacy of recombinant human alpha-galactosidase A\u2014replacement therapy in Fabry's disease. N Engl J Med 345:9\u201316","journal-title":"N Engl J Med"},{"key":"1051_CR17","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"R Schiffmann","year":"2001","unstructured":"Schiffmann R, Kopp JB, Austin HA 3rd, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO (2001) Enzyme replacement therapy in Fabry disease: a randomized controlled trial. J Am Med Assoc 285:2743\u20132749","journal-title":"J Am Med Assoc"},{"key":"1051_CR18","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","volume":"62","author":"BL Thurberg","year":"2002","unstructured":"Thurberg BL, Rennke H, Colvin RB, Dikman S, Gordon RE, Collins AB, Desnick RJ, O'Callaghan M (2002) Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int 62:1933\u20131946","journal-title":"Kidney Int"},{"key":"1051_CR19","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","volume":"94","author":"T Ohshima","year":"1997","unstructured":"Ohshima T, Murray GJ, Swaim WD, Longenecker G, Quirk JM, Cardarelli CO, Sugimoto Y, Pastan I, Gottesman MM, Brady RO, Kulkarni AB (1997) alpha-Galactosidase A deficient mice: a model of Fabry disease. Proc Natl Acad Sci USA 94:2540\u20132544","journal-title":"Proc Natl Acad Sci USA"},{"key":"1051_CR20","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1073\/pnas.96.11.6423","volume":"96","author":"T Ohshima","year":"1999","unstructured":"Ohshima T, Schiffmann R, Murray GJ, Kopp J, Quirk JM, Stahl S, Chan CC, Zerfas P, Tao-Cheng JH, Ward JM, Brady RO, Kulkarni AB (1999) Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice. Proc Natl Acad Sci USA 96:6423\u20136427","journal-title":"Proc Natl Acad Sci USA"},{"key":"1051_CR21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/316953","volume":"68","author":"YA Ioannou","year":"2001","unstructured":"Ioannou YA, Zeidner KM, Gordon RE, Desnick RJ (2001) Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice. Am J Hum Genet 68:14\u201325","journal-title":"Am J Hum Genet"},{"key":"1051_CR22","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","volume":"105","author":"JM Aerts","year":"2008","unstructured":"Aerts JM, Groener JE, Kuiper S, Donker-Koopman WE, Strijland A, Ottenhoff R, van Roomen C, Mirzaian M, Wijburg FA, Linthorst GE, Vedder AC, Rombach SM, Cox-Brinkman J, Somerharju P, Boot RG, Hollak CE, Brady RO, Poorthuis BJ (2008) Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci USA 105:2812\u20132817","journal-title":"Proc Natl Acad Sci USA"},{"key":"1051_CR23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2008.09.001","volume":"33","author":"LG Rodrigues","year":"2009","unstructured":"Rodrigues LG, Ferraz MJ, Rodrigues D, Pais-Vieira M, Lima D, Brady RO, Sousa MM, Sa-Miranda MC (2009) Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice. Neurobiol Dis 33:48\u201356","journal-title":"Neurobiol Dis"},{"key":"1051_CR24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.ASN.0000043901.45141.D4","volume":"14","author":"DT Eitzman","year":"2003","unstructured":"Eitzman DT, Bodary PF, Shen Y, Khairallah CG, Wild SR, Abe A, Shaffer-Hartman J, Shayman JA (2003) Fabry disease in mice is associated with age-dependent susceptibility to vascular thrombosis. J Am Soc Nephrol 14:298\u2013302","journal-title":"J Am Soc Nephrol"},{"key":"1051_CR25","doi-asserted-by":"crossref","first-page":"20960","DOI":"10.1074\/jbc.M702436200","volume":"282","author":"L Shu","year":"2007","unstructured":"Shu L, Shayman JA (2007) Caveolin-associated accumulation of globotriaosylceramide in the vascular endothelium of alpha-galactosidase A null mice. J Biol Chem 282:20960\u201320967","journal-title":"J Biol Chem"},{"key":"1051_CR26","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1440-1681.2008.04984.x","volume":"35","author":"JL Park","year":"2008","unstructured":"Park JL, Whitesall SE, D'Alecy LG, Shu L, Shayman JA (2008) Vascular dysfunction in the alpha-galactosidase A-knockout mouse is an endothelial cell-, plasma membrane-based defect. Clin Exp Pharmacol Physiol 35:1156\u20131163","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1051_CR27","doi-asserted-by":"crossref","first-page":"H1133","DOI":"10.1152\/ajpcell.00031.2009","volume":"296","author":"JL Park","year":"2009","unstructured":"Park JL, Shu L, Shayman JA (2009) Differential involvement of COX1 and COX2 in the vasculopathy associated with the alpha-galactosidase A-knockout mouse. Am J Physiol 296:H1133\u2013H1140","journal-title":"Am J Physiol"},{"key":"1051_CR28","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1681\/ASN.2008111190","volume":"20","author":"L Shu","year":"2009","unstructured":"Shu L, Park JL, Byun J, Pennathur S, Kollmeyer J, Shayman JA (2009) Decreased nitric oxide bioavailability in a mouse model of Fabry disease. J Am Soc Nephrol 20:1975\u20131985","journal-title":"J Am Soc Nephrol"},{"key":"1051_CR29","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215","journal-title":"Nucleic Acids Res"},{"key":"1051_CR30","unstructured":"Conti CJ, Gimenez-Conti IB, Benavides F, Frijhoff AFW, Conti MA (reviewed by) Ward JM (2004) Atlas of Laboratory Mouse Histology. Texas Histopages, Inc. http:\/\/ctrgenpath.net\/static\/atlas\/mousehistology . Accessed 2 January 2010"},{"key":"1051_CR31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-90-481-9033-1_12","volume-title":"Fabry disease","author":"DG Warnock","year":"2010","unstructured":"Warnock DG, Valbuena C, West M, Oliveira JP (2010) Renal manifestations of Fabry disease. In: Elstein D, Altarescu G, Beck M (eds) Fabry disease, 1st edn. Springer, Dordrecht, pp 211\u2013244","edition":"1"},{"key":"1051_CR32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/j.ajkd.2003.09.022","volume":"43","author":"SM Meehan","year":"2004","unstructured":"Meehan SM, Junsanto T, Rydel JJ, Desnick RJ (2004) Fabry disease: renal involvement limited to podocyte pathology and proteinuria in a septuagenarian cardiac variant. Pathologic and therapeutic implications. Am J Kidney Dis 43:164\u2013171","journal-title":"Am J Kidney Dis"},{"key":"1051_CR33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ki.2010.199","volume":"78","author":"FC Brosius","year":"2010","unstructured":"Brosius FC (2010) Susceptible mice: identifying a diabetic nephropathy disease locus using a murine model. Kidney Int 78:431\u2013432","journal-title":"Kidney Int"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-011-1051-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-011-1051-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-011-1051-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T15:12:51Z","timestamp":1560006771000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-011-1051-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,16]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["1051"],"URL":"https:\/\/doi.org\/10.1007\/s00428-011-1051-8","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,16]]}}}